P. Oger, C. Schwartz, C. Mabit, Michel-Henri Fessy, Sophie Putman, Nicolas Reina, Nassima Ramdane, D. Waast, Henri Migaud, Jean-Yves Jenny, E. Sari Ali, L.E. Gayet, E. de Thomasson, Romain Desmarchelier, Sfhg, Matthieu Ollivier, Philippe Chiron, Institut locomoteur (ILM), Hôpital Pierre-Paul Riquet [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse], Hôpital Salengro, CHU de Lille, Laboratoire de Biomécanique et Mécanique des Chocs (LBMC UMR T9406), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut Français des Sciences et Technologies des Transports, de l'Aménagement et des Réseaux (IFSTTAR), Service de chirurgie orthopédique et traumatologique [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de chirurgie orthopédique et traumatologique, Hôpital St. Marguerite, Hôpital de Hautepierre [Strasbourg], Hôtel-Dieu, Nantes, CHU Dupuytren, Institut Mutualiste de Montsouris (IMM), Centre d'orthopédie clinique des 3-frontières, Hopital A.-Mignot, Centre hospitalier universitaire de Poitiers (CHU Poitiers), Unité de biostatistique, pôle de santé publique, CHRU de Lille, Service de Chirurgie Orthopédique et Traumatologique [CHU Pitié-Salpêtrière], and Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Background Various factors contribute to instability of total hip arthroplasty (THA), with implant orientation being a major contributor. We performed a case-control study with computed tomography (CT) data to determine whether: 1) orientation contributes to THA instability and 2) a safer target zone for stability than Lewinnek's classic safe zone can be defined. Material and methods We included prospectively 363 cases of THA dislocation that occurred during the calendar 2013 year in 24 participating hospitals. Of the 128 dislocations that occurred in patients who underwent THA at these centers, 56 (24 anterior, 32 posterior) had CT scans, thus were included in the analysis. The control group was matched 4:1 based on implant type, year of implantation, age, sex, bearing types and THA indication. Of the 428 matched control THA cases, 93 had CT scans. In all, the CT scans from 149 cases (56 unstable, 93 stable) were analyzed to determine the acetabular cup's inclination and anteversion, and the femoral stem's anteversion. Results In the unstable THA group, cup inclination was 46.9° ± 7.4°, cup anteversion was 20.4° ± 10.8° and stem anteversion was 14.2° ± 9.9°. In the stable THA group, cup inclination was 44.9° ± 5.3° (P = 0.057), cup anteversion was 22.1° ± 5.1° (P = 0.009) and stem anteversion was 13.4° ± 4.4° (P = 0.362). The optimal total anteversion (cup + stem) of 40–60° was achieved in 16.5% of unstable THA cases and 13.9% of stable THA cases, thus this parameter does not predict stability (odds ratio [OR] of 0.40, P = 0.144). The cup was positioned in Lewinnek's safe zone in 44.6% of patients in the unstable group and 68.2% of those in the stable group (OR 3.74, P = 0.003). A target zone defined as 40–50° inclination and 15–30° anteversion was better able to distinguish between unstable cases (23.2%) and stable cases (71.6%) resulting in an OR of 13.91 (P Discussion Implant positioning was the only risk factor for instability found in this study. Moreover, our findings reinforce the theory put forward by other authors that Lewinnek's safe zone is not specific enough to differentiate between stable and unstable THA implantations. The target zone for acetabular cups proposed here (40–50° inclination and 15°–30° anteversion) is related to a lower risk of instability. This orientation can be used as a guide, but must be combined with other technical elements to optimize stability. By balancing stability and biomechanics, the 40–50° inclination and 15°–30° anteversion target zone redefines the optimal positioning window. Level of evidence III case-control study.